Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects

Vaccination toward SARS-CoV-2 reduced mortality and 'boosters' are being implemented. We offer scientific contribution about IgG production in the COVID-19 experienced population. From January 2021 to March 2021, 183 residents and staff from the Elderly Nursing Home "San Giuseppe Mosc...

Full description

Saved in:

Bibliographic Details
Published in:	Human vaccines & immunotherapeutics Vol. 18; no. 5; p. 2060018
Main Authors:	Borgonovo, Fabio, Stangalini, Carlo Alberto, Tinelli, Carmine, Mariani, Chiara, Mileto, Davide, Cossu, Maria Vittoria, Abbati, Laura, Bilardo, Lara, Gagliardi, Gloria, Cutrera, Miriam, Pellicciotta, Martina, Armiento, Luciana, Dedivitiis, Gianfranco, Capetti, Amedeo F., Rizzardini, Giuliano
Format:	Journal Article
Language:	English
Published:	United States Taylor & Francis 30.11.2022 Taylor & Francis Group
Subjects:	Aged Antibodies, Viral antibody BNT162 Vaccine Brief Report Coronavirus – Short Report covid-19 COVID-19 - prevention & control decline Humans igg Immunoglobulin G kinetics SARS-CoV-2 spike Vaccination vaccine COVID-19 SARS-CoV-2 vaccine antibody IgG decline kinetics spike
ISSN:	2164-5515, 2164-554X, 2164-554X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!